Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment

NCT01250548 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT01250548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01250548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment
Lead sponsor
Baylor Research Institute
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2014
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis